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Letter to the Editors
An unusual antibody reacting with pre-diluted 0.8% reagent RBCs and with 0.8% older (aged) RBCs
prepared at the time of testing
A 58-year-old, nontransfused, group O male
presented at hospital for pretransfusion testing prior to
surgery. The preoperative screens and initial panel
were performed using a gel test and reagent RBCs pre-
diluted with LISS to 0.8% by the manufacturer (Ortho-
Clinical Diagnostics, Inc., Raritan, NJ). All cells tested,
except the autocontrol, were 2+ positive. The patient’s
DAT was negative. The hospital had also performed
tube LISS crossmatches and screens but observed no
reactivity.
The sample was referred to our red cell reference
laboratory for investigation of a potential antibody to a
high-frequency antigen reacting only by gel test.
As is our standard testing protocol, the patient’s
serum sample was tested with a three-cell screen plus
an autocontrol using the following: LISS-antiglobulin
(ImmuAdd; Immucor Inc., Norcross, GA), ficin
antiglobulin technique (GammaZyme-F; Gamma
Biologicals Inc., Houston,TX), and a gel test using RBCs
diluted at the time of testing with Diluent 2
(MicroTyping Systems Inc., Pompano Beach, FL).
No reactivity was observed with any of the test
methods. This excluded clinically significant
alloantibodies to common RBC antigens and antibodies
to high-frequency antigens reacting by routine
methods currently used by our laboratory.
The hospital had tested the sample using a gel
method and pre-diluted RBC suspensions. Since our
center was also using Ortho’s pooled pre-diluted 0.8%
RBCs for high-volume donor screening, we tested this
patient’s serum against these pooled RBCs in gel and
also observed a 2+ reaction. Another lot number of the
pooled pre-diluted cells was available and the 2+
reaction was reproduced. This latter example was
washed (× 3) free of diluent with 0.9% normal saline
and retested. There was no change in reactivity. This
demonstrated that the reactivity was neither diluent-
dependent nor caused by something that could be
washed from the RBC surface.
Since this case was referred to us as a possible
antibody to a high-frequency antigen, we prepared a
selected panel of RBCs negative for high-frequency
antigens from our liquid inventory. We prepared the
RBCs as 0.8% suspensions in Diluent 2 and tested the
RBCs with the patient’s serum immediately by the gel
test. To this point, the only reactive RBCs had been
those that had been pre-diluted by the manufacturer.
We now had some 2+ reactions and some negative
results. We then observed that the only reactive RBCs
were greater than 3 months old at the time of testing.
We then tested older (aged) examples of previously
nonreactive RBCs, side by side, in the gel cards and
found that the older examples now gave us up to 2+
reactions. The DAT on these older RBCs was negative
using gel-IgG cards.
We then decided to “age” some reagent RBCs at
37°C overnight in a water bath and test them the next
day. The so-called “aged” cells gave 2+ reactions and
their “fresh” counterparts were nonreactive.
The patient’s serum and ten random male donor
sera were tested against two 0.8% pre-diluted, DAT-
negative screening cells by the gel technique. The
patient’s serum reacted 2+ with both reagent RBCs and
all ten of the donor sera were nonreactive.
These same donor sera were then tested in parallel
with the patient’s serum against DAT-negative RBCs
from one donor. The single-source RBCs were tested
“fresh,” i.e., 2 weeks from expiration, 3 months
postexpiration, and 6 months postexpiration. The
three RBC samples were diluted to 0.8% suspensions
and tested immediately using the gel test. The ten
donor sera were nonreactive with all cells tested but
the patient’s serum reacted as expected. No reactivity
was observed with the “fresh” RBCs, a 1+ reaction was
observed with the 3-month aged RBCs, and a 2+
reaction with the 6-month aged RBCs.
The conclusion was that a constituent of the
diluent used by Ortho to predilute their RBCs was
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producing an immediate effect on the RBC surface that
was detected by this patient’s serum, an effect not
apparent with other commercially prepared RBCs until
they were aged during storage. This effect was
demonstrable by gel test.
Although the unusual antibody observed in this
case had no relevance to treatment of the patient, it is
prudent to share abnormal findings with our
colleagues. Sharing such results enables us to better
understand the advantages and disadvantages of
different antibody screening techniques.
Jeff Trimble, BSc, ART(CSMLS), CLS (NCA)
Reference Laboratory Supervisor
Michigan Community Blood Centers
1036 Fuller Ave., NE
PO Box 1704
Grand Rapids, MI 49501-1704
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